Document Detail


Warfarin for Venous Thromboembolism Prophylaxis After Elective Hip or Knee Arthroplasty: Exploring the Evidence, Guidelines, and Challenges Remaining (January).
MedLine Citation:
PMID:  22202495     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND:Guidelines for the prevention of venous thromboembolism (VTE) after elective total hip or knee arthroplasty (THA/TKA) have been developed separately by the American Academy of Orthopaedic Surgeons (AAOS) and the American College of Chest Physicians (ACCP). Differences exist in approaches to preventing postoperative VTE through prophylaxis.OBJECTIVE:To compare trials using vitamin K antagonists (VKAs) and differences in guidelines to determine the benefits and drawbacks of warfarin for VTE prophylaxis following THA/TKA.DATA SOURCES:Guidelines from the AAOS published in 2009 and revised in 2011 and from the ACCP published in 2008 were compared for recommendations on the use of VKAs. A MEDLINE search from 1960 to November 2009 was conducted to identify pertinent articles on the use of warfarin or VKAs for VTE prophylaxis following THA/TKA. Search terms included warfarin, vitamin K antagonist, total hip or total knee replacement, and total hip or total knee arthroplasty.STUDY SELECTION AND DATA EXTRACTION:Only clinical trials in which warfarin was the primary agent for prophylaxis compared to other anticoagulants were included.DATA SYNTHESIS:Data on differences between guideline recommendations for the use of VKAs and the importance of a deep vein thrombosis or asymptomatic events were extracted. Thirteen comparative trials using VKAs for VTE prophylaxis and international normalized ratio (INR) targets were assessed. Overall, the incidence of bleeding tended to be lower with the use of VKAs, but thrombosis when including asymptomatic events was numerically higher when comparing INR targets. However, INR targets varied, with no comparative trials assessing the AAOS 2009 recommended INR target of 1.5-2.0. The AAOS guidelines initially recommended a longer duration of therapy and expressed stronger support for the use of aspirin for prophylaxis; however, in 2011, its guidelines were revised, with no specific recommendations as to agent, dose, or INR target goal.CONCLUSIONS:Warfarin is an effective agent to prevent VTE after elective THA/TKA. The most effective approach, including extended warfarin use up to 4 weeks or longer, has not been determined.
Authors:
William E Dager
Related Documents :
21821865 - Sustained disease remission and inhibition of radiographic progression in methotrexate-...
2969925 - Restenosis after successful percutaneous transluminal coronary angioplasty: serial angi...
15789395 - Effect of continuous quality improvement analysis on the delivery of primary percutaneo...
19544705 - Clinical results of unprotected left main coronary stenting.
10717255 - Interferon and ribavirin combination therapy: indications and schedules.
19630485 - Are multiple nephrostomy tubes necessary after multitract percutaneous nephrolithotomy?...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-27
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  -     ISSN:  1542-6270     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
< Sacramento, CA; Clinical Professor of Pharmacy, University of California-San Francisco School of Pharmacy, San Francisco; Clinical Professor of Medicine, UC Davis School of Medicine; Clinical Professor of Pharmacy, School of Pharmacy, University of Touro, Vallejo, CA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of Topical Tranexamic Acid or Aminocaproic Acid to Prevent Bleeding After Major Surgical Proce...
Next Document:  I-SAVE Study: Impact of Sedation, Analgesia, and Delirium Protocols Evaluated in the Intensive Care ...